Gossamer Bio Competitors and Similar CompaniesClear all
Gossamer Bio's competitors and similar companies include ImmPACT-Bio, Zymeworks, Coherus Oncology and Foghorn Therapeutics.
 Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 2003 | Founding Date 2010 | Founding Date 2016 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ Dublin 2, IE | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations Vancouver, CA HQ Seattle, US | Locations Redwood City, US HQ Camarillo, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 11820% increase | Employees 845% decrease | Employees 45519% increase | Employees 14736% decrease | Employees 1123% decrease |
Valuation ($) | Valuation ($) 208 m | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 85.6 m | Valuation ($) 452 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($170.4m) (FY, 2025) | Net income N/A | Net income ($81.1m) (FY, 2025) | Net income $168m (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 480m | Total funding raised $ 18m | Total funding raised $ 125.9m | Total funding raised $ 174.5m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
ImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company